What is another word for hydroxychloroquine-induced renal phospholipidosis?
Pronunciation: [hˈa͡ɪdɹəksɪklˌɔːɹə͡ʊkwˌa͡ɪnɪndjˈuːst ɹˈiːnə͡l fˌɒsfəlˌɪpɪdˈə͡ʊsɪs] (IPA) 
Hydroxychloroquine-induced renal phospholipidosis is a mouthful to say, and even harder to understand without a medical background. This term refers to a possible side effect of the drug hydroxychloroquine, which is used to treat conditions such as malaria, lupus, and rheumatoid arthritis. Renal refers to the kidneys and phospholipidosis indicates an increase in phospholipids in the cells. Synonyms for this condition might include hydroxychloroquine-associated kidney lipid accumulation, drug-induced renal lipidosis, or hydroxychloroquine-induced kidney lipid storage. While these terms may still sound complicated to the average person, they provide a clearer understanding of this potential side effect and its impact on the body.
